Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Preoperative diagnosis of BRCA1/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients.

Scientific reports - 20 Jul 2021

Woo Jinsun, Gwak Geumhee, Park Inseok, Bae Byung Noe, Lee Se Kyung, Chae Byung Joo, Yu Jonghan, Lee Jeong Eon, Kim Seok Won, Nam Seok Jin, Ryu Jai Min

Abstract excerpt

Decision to undergo risk-reducing mastectomy (RRM) needs to consider several factors, including patient's preference, surgeon's preference, family history, and genetic predisposition. The aim of this study was to examine whether preoperative diagnosis of BRCA1/2 mutation status could influence surgical decision-making in newly diagnosed breast cancer patients. We retrospectively reviewed ipsilateral breast cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Decision Making

Share to Mastectomy

Share to Odds Ratio

Share to Preoperative Care

Share to Risk Reduction Behavior

Source

Open in PubMed Open full text

Identifiers

PMID: 34285295
DOI: 10.1038/s41598-021-94195-4
PMCID: PMC8292311

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Preoperative diagnosis of BRCA1/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients.PMID 34285295Read ↗

Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer.Semantic proximity Read ↗

Genetic Diagnosis before Surgery has an Impact on Surgical Decision in BRCA Mutation Carriers with Breast Cancer.Semantic proximity Read ↗

Risk management decisions in women with BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test Result.Semantic proximity Read ↗

Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study.Semantic proximity Read ↗

Preoperative genetic testing affects surgical decision making in breast cancer patients.Semantic proximity Read ↗

Prophylactic mastectomies in patients with breast cancer and known germline pathogenetic variants: an Austrian registrySemantic proximity Read ↗

Risk reducing mastectomy in Norwegian BRCA1/2 carriers.Semantic proximity Read ↗

Evaluation of the indication of BRCA1/2 genetic tests in Iranian women and acceptance rate of risk-reducing surgeries in BRCA mutation carriers.Semantic proximity Read ↗

Rapid Genetic Testing for BRCA1 and BRCA2 Mutations at the Time of Breast Cancer Diagnosis: An Observational Study.Semantic proximity Read ↗

Preoperative risk assessment among women undergoing bilateral prophylactic mastectomy for cancer risk reduction.Semantic proximity Read ↗

When to Consider Risk-Reducing Mastectomy in BRCA1/BRCA2 Mutation Carriers with Advanced Stage Ovarian Cancer: a Case Study Illustrating the Genetic Counseling Challenges.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.